Cargando…

MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4

ABSTRACT: BACKGROUND: Overexpression of microRNA-182 (miR-182) is found in various human cancers, including non-small cell lung cancer (NSCLC). Our aim is to investigate the association of miR-182 expression with the sensitivity of NSCLC to cisplatin. METHODS: TaqMan RT-PCR or Western blot assay was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Fang-ling, Wang, Feng, Li, Mian-li, Yu, Ze-shun, Hao, Yan-zhang, Chen, Shao-shui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108001/ https://www.ncbi.nlm.nih.gov/pubmed/25012722 http://dx.doi.org/10.1186/1746-1596-9-143

Ejemplares similares

microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
por: LI, HAO, et al.
Publicado: (2014)

miR-150 Modulates Cisplatin Chemosensitivity and Invasiveness of Muscle-Invasive Bladder Cancer Cells via Targeting PDCD4 In Vitro
por: Lei, Ye, et al.
Publicado: (2014)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines
por: WANG, ZIRAN, et al.
Publicado: (2016)

Bone protection by inhibition of microRNA-182
por: Inoue, Kazuki, et al.
Publicado: (2018)

MicroRNA‐433‐3p enhances chemosensitivity of glioma to cisplatin by downregulating NR5A2
por: Li, Jun, et al.
Publicado: (2022)

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
por: Gąsiorkiewicz, Bartosz Mateusz, et al.
Publicado: (2020)

Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma
por: Golbakhsh, Mohammad Reza, et al.
Publicado: (2016)

Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans
por: Shiina, Marisa, et al.
Publicado: (2021)

PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells
por: FAN, GUI-LING, et al.
Publicado: (2015)

Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene
por: Jiang, Li-Peng, et al.
Publicado: (2017)

MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4
por: LIANG, XUE, et al.
Publicado: (2016)

MicroRNA-183/96/182 cluster in immunity and autoimmunity
por: Wang, Zhuang, et al.
Publicado: (2023)

Expression of microRNAs in HPV negative tonsil cancers and their regulation of PDCD4
por: Khoury, Samantha, et al.
Publicado: (2016)

MicroRNA-182 Regulates Neurite Outgrowth Involving the PTEN/AKT Pathway
por: Wang, Wu M., et al.
Publicado: (2017)

Identification of PDCD1 and PDCD1LG2 as Prognostic Biomarkers and Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2022)

Protective Effects and Mechanisms of MicroRNA-182 on Oxidative Stress in RHiN
por: Li, Lihua, et al.
Publicado: (2019)

MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in breast cancer
por: Zhang, Ling, et al.
Publicado: (2018)

Cell fate determination in cisplatin resistance and chemosensitization
por: Luong, Khanh V., et al.
Publicado: (2016)

Role of MicroRNA-223 and MicroRNA-182 as Novel Biomarkers in Early Detection of Colorectal Cancer
por: Mahmoud, Hala A, et al.
Publicado: (2022)

MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin
por: Zhang, Xin, et al.
Publicado: (2015)

MicroRNA-21 and PDCD4 expression during in vitro oocyte maturation in pigs
por: Wright, Elane C., et al.
Publicado: (2016)

MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4
por: Wan, Jianji, et al.
Publicado: (2018)

MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation
por: Wang, Yiwei, et al.
Publicado: (2019)

Targeted deletion of miR-182, an abundant retinal microRNA
por: Jin, Zi-Bing, et al.
Publicado: (2009)

Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2015)

Overexpression of Ulk2 inhibits proliferation and enhances chemosensitivity to cisplatin in non-small cell lung cancer
por: Cheng, Hong, et al.
Publicado: (2019)

microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4
por: Li, Zhenyang, et al.
Publicado: (2020)

MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1
por: Zhao, Jun, et al.
Publicado: (2018)

Epstein-Barr Virus_Encoded LMP1 Upregulates MicroRNA-21 to Promote the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin-Induced Apoptosis by Suppressing PDCD4 and Fas-L
por: Yang, Guang-Da, et al.
Publicado: (2013)

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2012)

Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma
por: Xiao, Yilei, et al.
Publicado: (2016)

MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
por: Lin, Hui-Ming, et al.
Publicado: (2018)

MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma
por: Shen, Fengmei, et al.
Publicado: (2014)

MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural Mesothelioma
por: Moody, Hannah L., et al.
Publicado: (2017)

The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target
por: Sameti, Pouriya, et al.
Publicado: (2023)

MicroRNA-182-5p Attenuates Asthmatic Airway Inflammation by Targeting NOX4
por: Wang, Zhiguang, et al.
Publicado: (2022)

Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer
por: Bajaj, Rajat, et al.
Publicado: (2020)

Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)

eIF4E promotes tumorigenesis and modulates chemosensitivity to cisplatin in esophageal squamous cell carcinoma
por: Liu, Ting, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gv9gmcp2rou7erc40s40k94ckp